ROBERT MATTHEW GELFAND M.D.
NPI 1407855612
Internal Medicine - Hematology & Oncology in New York, NY

Active since July 19, 2005PECOS EnrolledAccepts Medicare Assignment
98.2/100
CMS Quality Rating
1751 YORK AVE, NEW YORK, NY 10128(212) 879-3496(212) 879-3724 Get Directions Write a Review

NPPES record last updated: June 6, 2016. Verified against the NPPES registry weekly; last sync: August 02, 2026.

About Robert Matthew Gelfand M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

ROBERT MATTHEW GELFAND M.D. (NPI 1407855612) is an individual hematology & oncology provider in New York, New York, licensed in New York (186949) and active in the NPI registry since July 2005. He is enrolled in Medicare PECOS and is a graduate of State University Of New York Downstate Medical Center (1990).

NPPES Registry Identity

NPI1407855612
Entity TypeIndividualMale
Primary Taxonomy207RH0003X
Provider Legal NameROBERT MATTHEW GELFANDCredential: M.D.
Location Address1751 YORK AVENew York, NY 10128-6828
Mailing Address1751 York AveNew York, NY 10128-6828 · (212) 879-3496 · Fax (212) 879-3724
Fax(212) 879-3724
Sole ProprietorNo
Medical School CMSState University Of New York Downstate Medical CenterGraduated 1990
Enumeration DateJuly 19, 2005
Last NPPES UpdateJune 6, 2016
NPI 1407855612 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyInternal Medicine · Hematology & OncologyAllopathic & Osteopathic Physicians
Taxonomy Code207RH0003X
Licenses Licensed in NY · 186949 Licensed in NJ · 25MA09074900
Definition
An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
1751 YORK AVE, New York, NY 10128

Other Identifiers 4

Medicare PIN76061YQRQ1NY
Other3Z2111NY · Blue Cross / Blue Shield
Medicare UPING26506
Medicare PIN240457YHL8NJ

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Robert Matthew Gelfand M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID8325121403
PECOS Enrollment IDI20080213000116
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 47

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, romosozumab-aqqg, 1 mg J3111
Romosozumab-aqqg is a medication given by injection to treat osteoporosis in patients at high risk for fractures. It works by increasing bone mass and strength, reducing the risk of fractures.
122,011 services161 patients
Injection, denosumab, 1 mg J0897
Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
66,060 services832 patients
Injection, ferric carboxymaltose, 1 mg J1439
Ferric carboxymaltose is an iron supplement injection. It's given when your body needs more iron than you can consume through diet, like in anemia. The injection is administered by a healthcare professional into a vein.
60,000 services54 patients
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Q0138
Ferumoxytol injection is a treatment for iron deficiency anemia, a condition where your body lacks enough iron. It is injected into your vein to increase iron levels, aiding in the production of healthy red blood cells. This treatment is not for ESRD patients.
38,760 services48 patients
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg J1561
This is an injection of immune globulin, specifically Gamunex-C or Gammaked. It's a liquid form, not freeze-dried. Immune globulin is a blood product that helps your immune system to fight infections. It's given in a dose of 500 mg.
24,205 services38 patients
Injection, eptinezumab-jjmr, 1 mg J3032
Eptinezumab-jjmr is a medication given through injection to prevent migraines. It works by blocking a specific protein that may cause migraines. This injection is usually given every 3 months by a healthcare professional.
12,600 services22 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 10128 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$198.19 typical visit price
range $65.69 – $198.19
Typical copayment $49.54 (range $16.42 – $49.54)
Most-billed visit code 99205
Established Patient
$114.88 typical visit price
range $21.20 – $160.66
Typical copayment $28.72 (range $5.30 – $40.16)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

98.2/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Individually scored
Quality100
Promoting Interoperability94
Improvement Activities40

Reported Quality Measures

Advance Care Plan
100%602 patients5/55-star benchmark: 100%
Breast Cancer Screening
93%347 patients5/55-star benchmark: 93%
Colorectal Cancer Screening
100%562 patients5/55-star benchmark: 88%
Documentation of Current Medications in the Medical Record
99%2,165 patients4/55-star benchmark: 100%
Oncology: Medical and Radiation - Pain Intensity Quantified
100%218 patients5/55-star benchmark: 100%
Oncology: Medical and Radiation - Plan of Care for Pain
100%65 patients5/55-star benchmark: 100%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Patients screened: 100% · 335 patients
100%335 patients
Provide Patients Electronic Access to Their Health Information
89%1,463 patients4/55-star benchmark: 100%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Other Providers at the Same Location NPPES 16

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Anesthesiology
1751 YORK AVE
NEW YORK, NY 10128
Nurse Practitioner (Adult Health)
1751 YORK AVE
NEW YORK, NY 10128
Nurse Practitioner (Family)
1751 YORK AVE
NEW YORK, NY 10128
Internal Medicine (Gastroenterology)
1751 YORK AVE
NEW YORK, NY 10128
Anesthesiology
1751 YORK AVE
NEW YORK, NY 10128
Nurse Practitioner (Adult Health)
1751 YORK AVE
NEW YORK, NY 10128
Physician Assistant (Medical)
1751 YORK AVE
NEW YORK, NY 10128
Internal Medicine (Gastroenterology)
1751 YORK AVE
NEW YORK, NY 10128

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Robert Gelfand's NPI number?

The NPI number for Robert Gelfand is 1407855612. It was assigned to this individual provider in the NPPES registry on July 19, 2005.

Where is Robert Gelfand located?

Robert Gelfand practices at 1751 York Ave, New York, NY 10128. The listed phone number is (212) 879-3496.

What is Robert Gelfand's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Hematology & Oncology, with taxonomy code 207RH0003X.

Is Robert Gelfand enrolled in Medicare?

Yes. Robert Gelfand is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Robert Gelfand was last updated on June 6, 2016. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 10 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.